Clinical Trial Update: Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial update for optimizing NULOJIX usage to avoid calcineurin inhibitors and steroids in renal transplantation; the study is terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Renal Transplantation

Drugs mentioned

• Nulojix (belatacept)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Transplantation, Renal Transplantation | Phase 2 | Status: TERMINATED | Results posted: 2017-08-30